These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21867485)

  • 1. Aggregation of amyloids in a cellular context: modelling and experiment.
    Friedman R
    Biochem J; 2011 Sep; 438(3):415-26. PubMed ID: 21867485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
    Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid aggregation on lipid bilayers and its impact on membrane permeability.
    Friedman R; Pellarin R; Caflisch A
    J Mol Biol; 2009 Mar; 387(2):407-15. PubMed ID: 19133272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-folding and aggregation of amyloid nanofibrils.
    Paparcone R; Cranford SW; Buehler MJ
    Nanoscale; 2011 Apr; 3(4):1748-55. PubMed ID: 21347488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipids enhance apolipoprotein C-II-derived amyloidogenic peptide oligomerization but inhibit fibril formation.
    Hung A; Griffin MD; Howlett GJ; Yarovsky I
    J Phys Chem B; 2009 Jul; 113(28):9447-53. PubMed ID: 19537801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What the use of disease-unrelated model proteins can tell us about the molecular basis of amyloid aggregation and toxicity.
    Stefani M
    Ital J Biochem; 2003 Dec; 52(4):162-76. PubMed ID: 15141483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-lactoglobulin assembles into amyloid through sequential aggregated intermediates.
    Giurleo JT; He X; Talaga DS
    J Mol Biol; 2008 Sep; 381(5):1332-48. PubMed ID: 18590743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpreting the aggregation kinetics of amyloid peptides.
    Pellarin R; Caflisch A
    J Mol Biol; 2006 Jul; 360(4):882-92. PubMed ID: 16797587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological membranes as protein aggregation matrices and targets of amyloid toxicity.
    Bucciantini M; Cecchi C
    Methods Mol Biol; 2010; 648():231-43. PubMed ID: 20700716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational studies of the structure, dynamics and native content of amyloid-like fibrils of ribonuclease A.
    Colombo G; Meli M; De Simone A
    Proteins; 2008 Feb; 70(3):863-72. PubMed ID: 17803210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of kinetic pathways in amyloid fibril formation.
    Bellesia G; Shea JE
    J Chem Phys; 2009 Sep; 131(11):111102. PubMed ID: 19778093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics simulations of amyloid fibrils: an in silico approach.
    Ye W; Wang W; Jiang C; Yu Q; Chen H
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):503-8. PubMed ID: 23532062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics simulations and free energy analyses on the dimer formation of an amyloidogenic heptapeptide from human beta2-microglobulin: implication for the protofibril structure.
    Lei H; Wu C; Wang Z; Duan Y
    J Mol Biol; 2006 Mar; 356(4):1049-63. PubMed ID: 16403526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-scale modelling of amyloid formation from unfolded proteins using a set of theory derived rate constants.
    Hall D; Hirota N
    Biophys Chem; 2009 Mar; 140(1-3):122-8. PubMed ID: 19117660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amyloidosis: a model of misfolded protein disorder].
    Grateau G; Verine J; Delpech M; Ries M
    Med Sci (Paris); 2005; 21(6-7):627-33. PubMed ID: 15985206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of amyloidogenic peptides on bacterial aging correlates with their intrinsic aggregation propensity.
    Villar-Pique A; de Groot NS; Sabaté R; Acebrón SP; Celaya G; Fernàndez-Busquets X; Muga A; Ventura S
    J Mol Biol; 2012 Aug; 421(2-3):270-81. PubMed ID: 22200483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of alpha-synuclein aggregation.
    van Ham TJ; Esposito A; Kumita JR; Hsu ST; Kaminski Schierle GS; Kaminski CF; Dobson CM; Nollen EA; Bertoncini CW
    J Mol Biol; 2010 Jan; 395(3):627-42. PubMed ID: 19891973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte Carlo simulations of protein amyloid formation reveal origin of sigmoidal aggregation kinetics.
    Linse B; Linse S
    Mol Biosyst; 2011 Jul; 7(7):2296-303. PubMed ID: 21589952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
    Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
    J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.